AKR1C3 and gastric cancer: The lower the level of AKR1C3 in GC tissue or the higher the level in plasma, the worse the histopathological results and patient's clinical prognosis, which implies that AKR1C3 is a promising biomarker for the screening and prognostic assessment of GC.